Prognostic significance of tumor angiogenesis in epithelial ovarian cancer

Cancer Letters

Volumn 138, Issue 1-2, 1999, Pages 175-182

  Obermair, Andreas ^a   Wasicky, Richard ^a   Kaider, Alexandra ^b   Preyer, Oliver ^a   Lösch, Alexander ^c   Leodolter, Sepp ^a,d   Kölbl, Heinz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

Author keywords

Angiogenesis; Epithelial ovarian cancer; Prognosis

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0033606084     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00005-1     Document Type: Article

References (30)

1. Folkman J. Tumor angiogenesis: theraputic implications. New Engl. J. Med. 285:1971;1182-1186.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Med. 1:1995;27-31.
3. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New Engl. J. Med. 324:1991;1-8.
4. Gasparini G., Weidner N., Bevilacqua P., Maluta S., Palma P.D., Caffo O., Barbareschi M., Boracchi P., Marubini E., Pozza F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vascular space involvement are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol. 12:1994;454-466.
5. Obermair A., Kurz C., Czerwenka K., Thoma M., Kaider A., Wagner T., Gitsch G., Sevelda P. Microvessel density and vascular space involvement in lymphnode-negative breast cancer: effect on recurrence-free survival. Int. J. Cancer. 62:1995;126-131.
6. Kirschner C.V., Alanis-Amezcua J.M., Martin V.G., Luna N., Morgan E., Yang J.J., Yordan E.L. Angiogenesis factor in endometrial carcinoma: a new prognostic indicator? Am. J. Obstet. Gynecol. 174:1996;1879-1884.
7. Obermair A., Kohlberger P., Bancher-Todesca D., Tempfer C., Sliutz G., Reinthaller A., Kainz C., Breitenecker G., Gitsch G. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression on prognosis in vulvar cancer. Gynecol. Oncol. 63:1996;204-209.
8. Wiggins D., Granai C.O., Steinhoff M.M., Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol. Oncol. 56:1995;353-356.
9. Schlenger K., Höckel M., Mitze M., Schäffer U., Weikel W., Knapstein P.G., Lambert A. Tumor vascularity-a novel prognostic factor in advanced cervical carcinoma. Gynecol. Oncol. 59:1995;57-66.
10. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:1995;9-19.
11. McCulloch P., Choy A., Martin L. Association between tumor angiogenesis and tumor cell shedding into effluent venous blood during breast cancer surgery. Lancet. 346:1995;1334-1335.
12. Hollingsworth H.C., Kohn E.C., Steinberg S.M., Rothenberg M.L., Merino M.J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol. 147:1995;33-41.
13. Gasparini G., Bonoldi E., Viale G., Verderio P., Boracchi P., Panizzoni G.A., Radaelli U. Di Bacco. A., Gugliemi, R.B., Bevilacqua, P., Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas, Int. J. Cancer. 69:1996;205-211.
14. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., Sutherland D.R., Baker M.A., Greaves M.F. Expression of the CD34 gene in vascular endothelial cells. Blood. 75:1990;2417-2426.
15. Kuzu I., Bicknell R., Harris A.L., Jones M., Gatter K.C., Mason D.Y. Heterogenety of vascular endothelial cells with relevance to diagnosis of vascular tumours. J. Clin. Pathol. 45:1992;143-148.
16. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 36:1995;169-180.
17. Kruskal W.H., Wallis W.A. Use of ranks in one-criterion variance analysis. J. Am. Statist. Ass. 47:1952;583-621.
18. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J. Am. Statist. Ass. 53:1985;457-481.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:1966;163-170.
20. Cox D.R. Regression models and life tables. J. Roy. Stat. Soc. B. 34:1972;187-220.
21. Folkman, J., What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82, 4-6.
22. Yeo K.T., Wang H.H., Nagy J.A., Sioussat T.M., Ledbetter S.R., Hoogerwerf A.J., Zhou Y., Masse E.M., Senger D.R., Dvorak H.F., Yeo T.K. Vascular permeablity factor (Vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res. 53:1993;2912-2918.
23. Toi M., Kondo S., Suzuki H., Yamamoto Y., Inada K., Imazawa T., Taniguchi T., Tominaga T. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer. 77:1996;1101-1106.
24. Tempfer C., Obermair A., Hefler L., Häusler G., Gitsch G., Kainz C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet. Gynecol. 92:1998;360-363.
25. Doldi N., Bassan M., Gulisano M., Broccoli V., Boncinelli E., Ferrari A. Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. Gynecol. Oncol. 10:1996;375-382.
26. Olson T.A., Mohanraj D., Carson L.F., Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 54:1994;276-280.
27. Abu-Jawdeh G.M., Faix J.D., Niloff J., Tognazzi K., Manseau E., Dvorak H.F., Brown L.F. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab. Invest. 74:1996;1105-1115.
28. Yanase T., Tamura M., Fujita K., Kodama S., Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 53:1993;2566-2570.
29. Ray J.M., Stetler-Stevenson W.G. The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis, Eur. Respir. J. 7:1994;2062-2072.
30. Schoenfeld A., Levavi H., Breslavski D., Amir R., Ovadia J. Three-dimensional modelling of tumor-induced ovarian angiogenesis. Cancer Lett. 87:1994;79-84.